Phase 4 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have recently been diagnosed with peripartum cardiomyopathy (a type of heart condition that develops around the time of childbirth) for the first time
- People who have already given birth and are within the first 5 months after delivery
- People whose heart pumping strength (measured as LVEF) is at or below 40%, confirmed within 4 weeks of agreeing to join the main part of the trial
- People whose heart pumping strength is at or below 40%, confirmed within 8 weeks of agreeing to join the breastfeeding group of the trial
- People who are 18 years of age or older
Who may not be able to join:
- People who have previously been diagnosed with any heart muscle disease, heart valve disease, or a heart condition present from birth — except those who had peripartum cardiomyopathy in the past, fully recovered, and had a documented heart pumping strength above 55% before or early in a pregnancy
- People with very high blood pressure that is difficult to control (top number above 160 or bottom number above 95) either at the time of joining or at the time their heart function was measured
- People who are currently breastfeeding after giving birth and plan to keep breastfeeding
- People with evidence of significant blockages in the arteries that supply the heart (confirm with trial site)
- People who have previously had a heart transplant
- People currently using a long-term mechanical heart pump device (LVAD)
- People currently on a life-support machine that does the work of the heart and lungs (ECMO)
- People with a current history of alcohol or drug misuse
- People who have had chemotherapy or radiation treatment to the chest within the past 5 years
- People showing signs of an active serious bacterial infection in the bloodstream
- People with medical, social, or mental health conditions that would make it difficult to attend follow-up appointments or comply with the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dennis McNamara, University of Pittsburgh
Phone: 412-802-3131
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Left ventricular ejection fraction (LVEF) at 6 months post entry as determined by echocardiography
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.